Multiple Myeloma: Symptoms, Causes, and Treatment Options

Multiple myeloma is a cancer of plasma cells, a type of white blood cell found in bone marrow. It can affect bones, blood counts, kidneys, and immunity, but diagnosis and treatment have improved and many people can be managed with a personalized care plan.

Overview: what multiple myeloma is

Multiple myeloma is a cancer that starts in plasma cells, which are immune cells normally responsible for making antibodies to help the body fight infection. In multiple myeloma, abnormal plasma cells build up in the bone marrow and crowd out healthy blood-forming cells. They can also produce abnormal proteins that circulate in the blood or urine and may affect organs such as the kidneys.

This condition is considered a blood cancer, but its effects are often felt throughout the body. The abnormal cells may weaken bones, reduce red blood cell production, interfere with normal immunity, and raise calcium levels when bone breaks down. Because of this, multiple myeloma can cause a wide range of symptoms rather than one single warning sign.

Not everyone with plasma cell abnormalities has active cancer that needs treatment right away. Some people are first found to have related conditions such as monoclonal gammopathy of undetermined significance or smoldering myeloma, which are monitored closely because they can progress over time. A specialist helps distinguish these conditions from active multiple myeloma and decide when treatment is needed.

Symptoms and early signs

Multiple myeloma symptoms may develop slowly and can be mistaken for more common problems, especially in the early stages. Some people have no symptoms at first and learn about the condition after routine blood tests show anemia, abnormal protein levels, or kidney changes. Others seek care because of persistent discomfort or recurring infections.

Common symptoms and signs can include:

• Bone pain, especially in the back, ribs, hips, or shoulders
• Fatigue, weakness, or shortness of breath related to anemia
• Frequent or severe infections
• Unexplained weight loss or reduced appetite
• Numbness, tingling, or weakness if bones or tissue press on nerves
• Increased thirst, constipation, nausea, or confusion caused by high calcium levels
• Reduced urine output or swelling if kidney function is affected

Bone symptoms are especially important because myeloma can create areas of bone damage that increase the risk of fractures. A person may notice back pain that does not improve, loss of height, or pain after minimal strain. Ongoing fatigue, repeated infections, or new kidney-related symptoms should also be discussed with a doctor, particularly if more than one problem is present at the same time.

Why it happens and who is at risk

The exact cause of multiple myeloma is not fully understood. It develops when changes occur in the DNA of plasma cells, allowing them to grow out of control and survive longer than they should. These abnormal cells multiply in the bone marrow and produce a monoclonal protein, often called an M protein, which can be measured during testing.

Several factors are linked with a higher risk, although having a risk factor does not mean a person will definitely develop the disease. Risk tends to increase with age, and multiple myeloma is more often diagnosed in older adults. A family history of plasma cell disorders, certain environmental exposures, and having precursor conditions such as monoclonal gammopathy of undetermined significance may also increase risk.

Researchers also study how inherited traits, immune system changes, chronic inflammation, and genetic abnormalities in myeloma cells influence disease behavior. These details matter because multiple myeloma is not the same in every person. Some forms grow slowly, while others are more aggressive, which is one reason a thorough hematology-oncology assessment is important from the start.

How doctors diagnose and stage multiple myeloma

Diagnosis usually begins with a careful review of symptoms, medical history, and a physical examination. If multiple myeloma is suspected, doctors typically order blood tests to look for anemia, kidney function changes, calcium levels, and abnormal proteins. Urine tests may also be used to detect light chains or other protein changes linked to plasma cell disease.

A bone marrow biopsy is an important part of confirming the diagnosis because it shows how many plasma cells are present and allows specialists to study their genetic features. Imaging is also used to check for bone damage or soft tissue involvement. Depending on the situation, this may include X-rays, low-dose CT, MRI, or PET/CT. In some cases, advanced PET/CT imaging helps assess where the disease is active and whether bones or other tissues are affected.

Doctors then stage the disease using laboratory markers and sometimes genetic results from the myeloma cells. Staging helps estimate how active the disease is and supports treatment planning, but it is only one part of the picture. Kidney function, symptoms, age, overall fitness, and whether the disease is newly diagnosed or has returned all influence the care plan. Evaluation may also include tests related to bone marrow transplant eligibility if intensive treatment is being considered.

Treatment options and how care is individualized

Multiple myeloma treatment is highly personalized. Some people with very early, symptom-free disease are monitored closely without immediate treatment, while active myeloma usually requires therapy. The main goals are to control abnormal plasma cells, relieve symptoms, protect organs, reduce complications, and help the person maintain quality of life.

Treatment often combines several approaches. Common options include targeted therapies, immunomodulatory medicines, corticosteroids, and other anti-myeloma drugs. Many patients also receive supportive treatments such as medicines to strengthen bones, fluids and kidney-protective measures, antibiotics or vaccines when appropriate, and pain management. When symptoms involve fragile or damaged bones, radiation therapy may sometimes be used to relieve localized pain or treat specific problem areas.

For some patients, especially those who are fit enough for intensive treatment, high-dose therapy followed by stem cell support may be recommended. In suitable cases, a specialist may discuss stem cell transplant as part of the treatment pathway. Newer therapies, including antibody-based treatments and other immune-directed strategies, have expanded options for people whose disease returns or becomes harder to control. Because treatment plans can change over time, regular follow-up is a central part of care.

Supportive care is not separate from treatment; it is part of good treatment. Managing anemia, bone health, infection risk, and kidney protection can make a major difference in daily well-being. A multidisciplinary team may include hematologists, oncologists, radiologists, nephrologists, pain specialists, and rehabilitation professionals to address the full impact of the disease.

Living with multiple myeloma: self-care and complication prevention

Although multiple myeloma requires specialist care, daily habits can support overall health during and after treatment. People are often advised to stay well hydrated unless a doctor has given fluid restrictions, eat a balanced diet, and keep all scheduled appointments for blood tests and monitoring. Good communication with the care team helps manage side effects early and reduces the chance of avoidable complications.

Bone protection is especially important. A doctor may recommend activity adjustments to lower the risk of fractures, along with supervised exercise or physical therapy to maintain strength and mobility. Heavy lifting or high-impact activities may need to be limited in some cases. Patients should also tell their team promptly about new back pain, sudden weakness, or numbness, as these can signal urgent bone or nerve problems.

Because immunity may be affected by both the disease and its treatment, infection prevention matters. Practical steps include hand hygiene, staying up to date with vaccinations recommended by the medical team, and seeking advice early for fever or signs of infection. People should not start supplements, pain medicines, or over-the-counter remedies without checking first, since some products can affect kidneys or interact with treatment.

When to seek medical care

A person should arrange medical evaluation if they have persistent bone pain, unusual fatigue, repeated infections, unexplained weight loss, or symptoms that suggest anemia or kidney problems. These symptoms do not always mean multiple myeloma, but they deserve assessment, especially when they continue, worsen, or occur together. Early evaluation can help identify the cause and guide the right next steps.

Urgent medical attention is important for severe back pain, sudden weakness in the legs, confusion, marked dehydration, very low urine output, fever during treatment, or signs of a fracture. These symptoms may reflect complications such as spinal cord compression, high calcium levels, infection, or kidney injury and should not be ignored.

After diagnosis, regular follow-up remains essential even if symptoms improve. Monitoring helps doctors assess treatment response, detect relapse, and manage long-term effects. For international patients, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat multiple myeloma with coordinated care tailored to each person’s condition.

Frequently asked questions

Is multiple myeloma curable?

Multiple myeloma is usually considered a treatable but often long-term condition rather than one that is permanently cured in most patients. Many people respond well to treatment, and modern therapies can control the disease for extended periods. The outlook varies based on stage, genetics, general health, and response to therapy.

What is usually the first symptom of multiple myeloma?

There is not one single first symptom for everyone. Common early problems include persistent bone pain, tiredness from anemia, or repeated infections. Some people have no symptoms at first and are diagnosed after routine blood tests show abnormal results.

Who gets multiple myeloma most often?

Multiple myeloma is more commonly diagnosed in older adults, although it can occur at different ages. Risk may also be higher in people with certain precursor plasma cell conditions or a family history of related disorders. A doctor can help interpret individual risk in the context of personal medical history.

How is multiple myeloma different from other blood cancers?

Multiple myeloma specifically involves plasma cells, which are antibody-producing cells in the bone marrow. Unlike some other blood cancers, it often causes bone damage, abnormal protein production, kidney problems, and changes in calcium levels. Its diagnosis and treatment approach are therefore distinct from leukemia or many lymphomas.

Can multiple myeloma be found on a routine blood test?

Routine blood tests may raise suspicion, especially if they show anemia, kidney problems, high calcium, or unusual protein levels. However, diagnosis usually requires more specific testing, such as serum and urine protein studies, imaging, and a bone marrow biopsy. These tests confirm whether the abnormal findings are due to multiple myeloma or another cause.

What should patients avoid if they have multiple myeloma?

Patients should avoid self-medicating without professional advice, especially with products that may strain the kidneys or interact with cancer treatment. They may also need to avoid activities that increase fracture risk if bones are weakened. The safest approach is to ask the care team about exercise, pain relief, supplements, and infection precautions.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.